Literature DB >> 12440358

Cell death in models of spinal cord injury.

Michael S Beattie1, Gerlinda E Hermann, Richard C Rogers, Jacqueline C Bresnahan.   

Abstract

Current treatments for acute spinal cord injury are based on animal models of human spinal cord injury (SCI). These models have shown that the initial traumatic injury to cord tissue is followed by a long period of secondary injury that includes a number of cellular and biochemical cascades. These secondary injury processes are potential targets for therapies. Continued refinement of rat and mouse models of SCI, along with more detailed analyses of the biology of the lesion in these models, points to both necrotic and apoptotic mechanisms of cell death after SCI. In this chapter, we review recent evidence for long-term apoptotic death of oligodendrocytes in long tracts undergoing Wallerian degeneration following SCI. This process appears to be related closely to activation of microglial cells. It is has been thought that microglial cells might be the source of cytotoxic cytokines, such as tumor necrosis factor-alpha (TNF-alpha), that kill oligodendrocytes. However, more recent evidence in vivo suggests that TNF-alpha by itself may not induce necrosis or apoptosis in oligodendrocytes. We review data that suggests other possible pathways for apoptosis, such as the neurotrophin receptor p75 which is expressed in both neurons and oligodendrocytes after SCI in rats and mice. In addition, it appears that microglial activation and TNF-alpha may be important in acute SCI. Ninety minutes after a moderate contusion lesion, microglia are activated and surround dying neurons. In an 'atraumatic' model of SCI, we have now shown that TNF-alpha appears to greatly potentiate cell death mediated by glutamate receptors. These studies emphasize that multiple mechanisms and interactions contribute to secondary injury after SCI. Continued study of both contusion models and other new approaches to studying these mechanisms will be needed to maximize strategies for acute and chronic therapies, and for neural repair.

Entities:  

Mesh:

Year:  2002        PMID: 12440358     DOI: 10.1016/s0079-6123(02)37006-7

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  145 in total

1.  Kainate-mediated excitotoxicity induces neuronal death in the rat spinal cord in vitro via a PARP-1 dependent cell death pathway (Parthanatos).

Authors:  Anujaianthi Kuzhandaivel; Andrea Nistri; Miranda Mladinic
Journal:  Cell Mol Neurobiol       Date:  2010-05-26       Impact factor: 5.046

Review 2.  Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.

Authors:  Arsalan Alizadeh; Soheila Karimi-Abdolrezaee
Journal:  J Physiol       Date:  2016-03-29       Impact factor: 5.182

Review 3.  Microglia.

Authors:  Denise van Rossum; Uwe-Karsten Hanisch
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

Review 4.  Multipotent skin-derived precursors: adult neural crest-related precursors with therapeutic potential.

Authors:  Karl J L Fernandes; Jean G Toma; Freda D Miller
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

5.  Rapid induction of genes associated with tissue protection and neural development in contused adult spinal cord after radial glial cell transplantation.

Authors:  Yu-Wen Chang; Loyal A Goff; Hedong Li; Noriko Kane-Goldsmith; Evangeline Tzatzalos; Ronald P Hart; Wise Young; Martin Grumet
Journal:  J Neurotrauma       Date:  2009-07       Impact factor: 5.269

6.  Multiple channel bridges for spinal cord injury: cellular characterization of host response.

Authors:  Yang Yang; Laura De Laporte; Marina L Zelivyanskaya; Kevin J Whittlesey; Aileen J Anderson; Brian J Cummings; Lonnie D Shea
Journal:  Tissue Eng Part A       Date:  2009-11       Impact factor: 3.845

7.  Diffusion tensor imaging as a predictor of locomotor function after experimental spinal cord injury and recovery.

Authors:  Brian J Kelley; Noam Y Harel; Chang-Yeon Kim; Xenophon Papademetris; Daniel Coman; Xingxing Wang; Omar Hasan; Adam Kaufman; Ronen Globinsky; Lawrence H Staib; William B J Cafferty; Fahmeed Hyder; Stephen M Strittmatter
Journal:  J Neurotrauma       Date:  2014-07-08       Impact factor: 5.269

Review 8.  Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases.

Authors:  Epiphani C Simmons; Natalie E Scholpa; Rick G Schnellmann
Journal:  Exp Neurol       Date:  2020-04-11       Impact factor: 5.330

9.  A Neurosphere Assay to Evaluate Endogenous Neural Stem Cell Activation in a Mouse Model of Minimal Spinal Cord Injury.

Authors:  Nishanth Lakshman; Wenjun Xu; Cindi M Morshead
Journal:  J Vis Exp       Date:  2018-09-13       Impact factor: 1.355

Review 10.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.